Blood banking and transfusion medicine challenges during the COVID-19 pandemic

SARS-CoV-2 (also known as COVID-19) has been unprecedented challenge in many parts of the medical field with blood banking being no exception. COVID-19 has had a distinctly negative effect on our blood collection nationwide forcing blood banks, blood centers, and the U.S. government to adopt new pol...

Full description

Autores:
Tipo de recurso:
Article of investigation
Fecha de publicación:
2020
Institución:
Universidad de Bogotá Jorge Tadeo Lozano
Repositorio:
Expeditio: repositorio UTadeo
Idioma:
eng
OAI Identifier:
oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12570
Acceso en línea:
https://doi.org/10.1016/j.cll.2020.08.013
http://hdl.handle.net/20.500.12010/12570
Palabra clave:
COVID-19
Blood banking
Transfusion medicine
Blood shortage
Blood wastage
FDA donation policies
Convalescent plasma
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
Rights
License
Acceso restringido
Description
Summary:SARS-CoV-2 (also known as COVID-19) has been unprecedented challenge in many parts of the medical field with blood banking being no exception. COVID-19 has had a distinctly negative effect on our blood collection nationwide forcing blood banks, blood centers, and the U.S. government to adopt new policies to adapt to a decreased blood supply as well as to protect our donors from COVID-19. These policies can be seen distinctly in patient blood management and blood bank operations. We are also faced with developing policies and procedures for a nontraditional therapy, convalescent plasma; its efficacy and safety is still not completely elucidated as of yet.